PDK1: The major transducer of PI 3-kinase actions

Current Topics in Microbiology and Immunology

Volumn 346, Issue 1, 2010, Pages 9-29

  Bayascas, José Ramón ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; S6 KINASE; SERUM AND GLUCOCORTICOID REGULATED KINASE; UNCLASSIFIED DRUG; 3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE; CRTC1 PROTEIN, HUMAN; CRTC2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR;

ARTICLE; CANCER GROWTH; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DIABETES MELLITUS; DRUG DESIGN; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STRUCTURE; GENETIC ANALYSIS; GENETIC MODEL; HUMAN; HYDROPHOBICITY; LYMPHOCYTOPOIESIS; MALIGNANT NEOPLASTIC DISEASE; METABOLIC REGULATION; MOLECULAR DOCKING; MOLECULAR INTERACTION; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; T LYMPHOCYTE; TISSUE SPECIFICITY; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS;

EID: 79952110243     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-43     Document Type: Article

References (117)

1. Ahmed N, Riley C, Quinn MA (2008) An immunohistochemical perspective of PPAR beta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours. Br J Cancer 98(8):1415-1424 (Pubitemid 351543574)
2. Alessi DR, Deak M, Casamayor A, Caudwell FB, Morrice N, Norman DG, Gaffney P, Reese CB, MacDougall CN, Harbison D, Ashworth A, Bownes M (1997a) 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol 7(10):776-789 (Pubitemid 27441832)
3. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P (1997b) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7(4):261-269 (Pubitemid 27176852)
4. Alessi DR, Kozlowski MT, Weng QP, Morrice N, Avruch J (1998) 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol 8(2):69-81 (Pubitemid 28104519)
5. Alessi DR, Pearce LR, Garcia-Martinez JM (2009) New insights into mTOR signaling: mTORC2 and beyond. Sci Signal 2(67):e27
6. Andjelkovic M, Alessi DR, Meier R, Fernandez A, Lamb NJ, Frech M, Cron P, Cohen P, Lucocq JM, Hemmings BA (1997) Role of translocation in the activation and function of protein kinase B. J Biol Chem 272(50):31515-31524 (Pubitemid 28013293)
7. Anjum R, Blenis J (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9(10):747-758
8. Balendran A, Casamayor A, Deak M, Paterson A, Gaffney P, Currie R, Downes CP, and Alessi DR (1999) PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol 9(8):393-404 (Pubitemid 29205782)
9. Balendran A, Biondi RM, Cheung PC, Casamayor A, Deak M, and Alessi DR (2000a) A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Czeta (PKCzeta) and PKC-related kinase 2 by PDK1. J Biol Chem 275(27):20806-20813 (Pubitemid 30457673)
10. Balendran A, Hare GR, Kieloch A, Williams MR, and Alessi DR (2000b) Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett 484(3):217-223
11. Bayascas JR, Alessi DR (2005) Regulation of Akt/PKB Ser473 phosphorylation. Mol Cell 18(2):143-145
12. Bayascas JR, Leslie NR, Parsons R, Fleming S, Alessi DR (2005) Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN(+/-) mice. Curr Biol 15(20):1839-1846 (Pubitemid 41501519)
13. Bayascas JR, Sakamoto K, Armit L, Arthur JS, Alessi DR (2006) Evaluation of approaches to generation of tissue-specific knock-in mice. J Biol Chem 281(39):28772-28781 (Pubitemid 44507020)
14. Bayascas JR, Wullschleger S, Sakamoto K, Garcia-Martinez JM, Clacher C, Komander D, Van Aalten DM, Boini KM, Lang F, Lipina C, Logie L, Sutherland C, Chudek JA, van Diepen JA, Voshol PJ, Lucocq JM, Alessi DR (2008) Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance. Mol Cell Biol 28(10):3258-3272 (Pubitemid 351657090)
15. Biddinger SB, Kahn CR (2006) From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123-158
16. Biondi RM (2004) Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation. Trends Biochem Sci 29(3):136-142 (Pubitemid 38314859)
17. Biondi RM, Cheung PC, Casamayor A, Deak M, Currie RA, Alessi DR (2000) Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA. EMBO J 19(5):979-988 (Pubitemid 30119823)
18. Biondi RM, Kieloch A, Currie RA, Deak M, and Alessi DR (2001) The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J 20(16):4380-4390. (Pubitemid 32772032)
19. Biondi RM, Komander D, Thomas CC, Lizcano JM, Deak M, Alessi DR, Van Aalten DM (2002) High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site. EMBO J 21(16):4219-4228
20. Calleja V, Alcor D, Laguerre M, Park J, Vojnovic B, Hemmings BA, Downward J, Parker PJ, Larijani B (2007) Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol 5(4):e95
21. Calleja V, Laguerre M, Parker PJ, Larijani B (2009) Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol 7(1):e17
22. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296(5573):1655-1657 (Pubitemid 34579158)
23. Casamayor A, Morrice NA, Alessi DR (1999) Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem J 342(Pt 2):287-292 (Pubitemid 29425348)
24. Chalhoub N, Zhu G, Zhu X, Baker SJ (2009) Cell type specificity of PI3K signaling in Pdk1-and Pten-deficient brains. Genes Dev 23(14):1619-1624
25. Chou MM, Hou W, Johnson J, Graham LK, Lee MH, Chen CS, Newton AC, Schaffhausen BS, Toker A (1998) Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr Biol 8 (19):1069-1077 (Pubitemid 28451031)
26. Chung J, Kuo CJ, Crabtree GR, Blenis J (1992) Rapamycin-FKBP specifically blocks growthdependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69(7):1227-1236
27. Collins BJ, Deak M, Arthur JS, Armit LJ, Alessi DR (2003) In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. EMBO J 22(16):4202-4211 (Pubitemid 37021748)
28. Collins BJ, Deak M, Murray-Tait V, Storey KG, Alessi DR (2005) In vivo role of the phosphate groove of PDK1 defined by knockin mutation. J Cell Sci 118(Pt 21):5023-5034 (Pubitemid 41672433)
29. Currie RA, Walker KS, Gray A, Deak M, Casamayor A, Downes CP, Cohen P, Alessi DR, Lucocq J (1999) Role of phosphatidylinositol 3, 4, 5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem J 337(Pt 3): 575-583
30. Dalby KN, Morrice N, Caudwell FB, Avruch J, Cohen P (1998) Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J Biol Chem 273(3):1496-1505 (Pubitemid 28133672)
31. Dann SG, Selvaraj A, Thomas G (2007) mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13(6):252-259 (Pubitemid 46836871)
32. Dettori R, Sonzogni S, Meyer L, Lopez-Garcia LA, Morrice NA, Zeuzem S, Engel M, Piiper A, Neimanis S, Frodin M, Biondi RM (2009) Regulation of the interaction between protein kinase C-related protein kinase 2 (PRK2) and its upstream kinase, 3-phosphoinositide-dependent protein kinase 1 (PDK1). J Biol Chem 284(44):30318-30327
33. Di CA, Pesce B, Cordon-Cardo C, Pandolfi PP (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet 19(4):348-355 (Pubitemid 28357906)
34. Dummler B, Hemmings BA (2007) Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 35(Pt 2):231-235 (Pubitemid 46596476)
35. Dutil EM, Toker A, Newton AC (1998) Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr Biol 8(25):1366-1375 (Pubitemid 29020145)
36. Engel M, Hindie V, Lopez-Garcia LA, Stroba A, Schaeffer F, Adrian I, Imig J, Idrissova L, Nastainczyk W, Zeuzem S, Alzari PM, Hartmann RW, Piiper A, Biondi RM (2006) Allosteric activation of the protein kinase PDK1 with low molecular weight compounds. EMBO J 25 (23):5469-5480 (Pubitemid 44847188)
37. Finlay DK, Sinclair LV, Feijoo C, Waugh CM, Hagenbeek TJ, Spits H, Cantrell DA (2009) Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes. J Exp Med 206(11): 2441-2454
38. Foller M, Mahmud H, Koka S, Lang F (2008) Reduced Ca2+ entry and suicidal death of erythrocytes in PDK1 hypomorphic mice. Pflugers Arch 455(5):939-949 (Pubitemid 350265619)
39. Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, Carr SA, Sabatini DM (2006) mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 16(18):1865-1870 (Pubitemid 44354144)
40. Frodin M, Jensen CJ, Merienne K, Gammeltoft S (2000) A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J 19(12):2924-2934 (Pubitemid 30386764)
41. Frodin M, Antal TL, Dummler BA, Jensen CJ, Deak M, Gammeltoft S, Biondi RM (2002) A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J 21(20):5396-5407 (Pubitemid 35231019)
42. Garcia-Martinez JM, Alessi DR (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum-and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416(3):375-385
43. Garcia-Martinez JM, Moran J, Clarke RG, Gray A, Cosulich SC, Chresta CM, Alessi DR (2009) Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). Biochem J 421(1):29-42
44. Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12(1):9-22 (Pubitemid 47001784)
45. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, Sabatini DM (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11(6):859-871 (Pubitemid 44804279)
46. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J, Yonezawa K (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110 (2):177-189 (Pubitemid 34876546)
47. Hashimoto N, Kido Y, Uchida T, Asahara S, Shigeyama Y, Matsuda T, Takeda A, Tsuchihashi D, Nishizawa A, Ogawa W, Fujimoto Y, Okamura H, Arden KC, Herrera PL, Noda T, Kasuga M (2006) Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat Genet 38(5):589-593
48. Hauge C, Frodin M (2006) RSK and MSK in MAP kinase signalling. J Cell Sci 119(Pt 15): 3021-3023 (Pubitemid 44322115)
49. Hauge C, Antal TL, Hirschberg D, Doehn U, Thorup K, Idrissova L, Hansen K, Jensen ON, Jorgensen TJ, Biondi RM, Frodin M (2007) Mechanism for activation of the growth factoractivated AGC kinases by turn motif phosphorylation. EMBO J 26(9):2251-2261 (Pubitemid 46685864)
50. Hindie V, Stroba A, Zhang H, Lopez-Garcia LA, Idrissova L, Zeuzem S, Hirschberg D, Schaeffer F, Jorgensen TJ, Engel M, Alzari PM, Biondi RM (2009) Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1. Nat Chem Biol 5(10):758-764
51. Hinton HJ, Alessi DR, Cantrell DA (2004) The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development. Nat Immunol 5(5):539-545 (Pubitemid 38660467)
52. Iorns E, Lord CJ, Ashworth A (2009) Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization. Biochem J 417(1):361-370
53. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, Su B (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127(1):125-137 (Pubitemid 44466632)
54. Jensen CJ, Buch MB, Krag TO, Hemmings BA, Gammeltoft S, Frodin M (1999) 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1. J Biol Chem 274(38):27168-27176
55. Kelly AP, Hinton HJ, Clarke RG, Cantrell DA (2006) Phosphoinositide- dependent kinase l (PDK1) haplo-insufficiency inhibits production of alpha/beta (alpha/beta) but not gamma delta (gamma/delta) T lymphocytes. FEBS Lett 580(8):2135-2140
56. Kelly AP, Finlay DK, Hinton HJ, Clarke RG, Fiorini E, Radtke F, Cantrell DA (2007) Notchinduced T cell development requires phosphoinositide-dependent kinase 1. EMBO J 26 (14):3441-3450 (Pubitemid 47123527)
57. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110(2):163-175 (Pubitemid 34876545)
58. Kim DH, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H, Tempst P, Sabatini DM (2003) GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 11(4):895-904 (Pubitemid 36566312)
59. Kobayashi T, Cohen P (1999) Activation of serum-and glucocorticoid- regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositidedependent protein kinase-1 (PDK1) and PDK2. Biochem J 339(Pt 2):319-328 (Pubitemid 29209961)
60. Komander D, Fairservice A, Deak M, Kular GS, Prescott AR, Peter DC, Safrany ST, Alessi DR, van Aalten DM (2004) Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO J 23(20):3918-3928 (Pubitemid 39472414)
61. Komander D, Kular G, Deak M, Alessi DR, Van Aalten DM (2005) Role of T-loop phosphorylation in PDK1 activation, stability, and substrate binding. J Biol Chem 280(19):18797-18802 (Pubitemid 41379581)
62. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V (2006) (Patho) physiological significance of the serum-and glucocorticoid-inducible kinase isoforms. Physiol Rev 86(4):1151-1178 (Pubitemid 44521650)
63. Lawlor MA, Mora A, Ashby PR, Williams MR, Murray-Tait V, Malone L, Prescott AR, Lucocq JM, Alessi DR (2002) Essential role of PDK1 in regulating cell size and development in mice. EMBO J 21(14):3728-3738 (Pubitemid 34787046)
64. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ (1998) Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281(5385):2042-2045 (Pubitemid 28475494)
65. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275(5308):1943-1947 (Pubitemid 27148818)
66. Lindsley CW, Barnett SF, Yaroschak M, Bilodeau MT, Layton ME (2007) Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors. Curr Top Med Chem 7 (14):1349-1363 (Pubitemid 47484764)
67. Lizcano JM, Alessi DR (2002) The insulin signalling pathway. Curr Biol 12(7):R236-R238
68. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129(7):1261-1274 (Pubitemid 46962095)
69. Maurer M, Su T, Saal LH, Koujak S, Hopkins BD, Barkley CR, WuJ, Nandula S, Dutta B, Xie Y, Chin YR, Kim DI, Ferris JS, Gruvberger-Saal SK, Laakso M, Wang X, Memeo L, Rojtman A, Matos T, Yu JS, Cordon-Cardo C, Isola J, TerryMB, Toker A,Mills GB, Zhao JJ, Murty VV, Hibshoosh H, Parsons R (2009) 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. Cancer Res 69(15):6299-6306
70. McManus EJ, Collins BJ, Ashby PR, Prescott AR, Murray-Tait V, Armit LJ, Arthur JS, Alessi DR (2004) The in vivo role of PtdIns(3, 4, 5)P3 binding to PDK1 PH domain defined by knockin mutation. EMBO J 23(10):2071-2082 (Pubitemid 38737734)
71. Mellor H, Parker PJ (1998) The extended protein kinase C superfamily. Biochem J 332(Pt 2): 281-292 (Pubitemid 28271856)
72. Milburn CC, Deak M, Kelly SM, Price NC, Alessi DR, Van Aalten DM (2003) Binding of phosphatidylinositol 3, 4, 5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. Biochem J 375(Pt 3):531-538 (Pubitemid 37433501)
73. Mora A, Davies AM, Bertrand L, Sharif I, Budas GR, Jovanovic S, Mouton V, Kahn CR, Lucocq JM, Gray GA, Jovanovic A, Alessi DR (2003) Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J 22(18):4666-4676 (Pubitemid 37162903)
74. Mora A, Komander D, Van Aalten DM, Alessi DR (2004) PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 15(2):161-170 (Pubitemid 38251644)
75. Mora A, Lipina C, Tronche F, Sutherland C, Alessi DR (2005) Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure. Biochem J 385(Pt 3):639-648 (Pubitemid 40208823)
76. Newton AC (2001) Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 101(8):2353-2364 (Pubitemid 35373023)
77. Newton AC (2003) Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370(Pt 2):361-371 (Pubitemid 36315124)
78. Newton AC (2010) Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 298(3): E395-E402
79. Okamoto Y, Ogawa W, Nishizawa A, Inoue H, Teshigawara K, Kinoshita S, Matsuki Y, Watanabe E, Hiramatsu R, Sakaue H, Noda T, Kasuga M(2007) Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK1. Diabetes 56(4):1000-1009 (Pubitemid 46525078)
80. Parekh D, Ziegler W, Yonezawa K, Hara K, Parker PJ (1999) Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon. J Biol Chem 274(49):34758-34764 (Pubitemid 129509518)
81. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA (1999) Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 18(11):3024-3033 (Pubitemid 29255611)
82. Pearce LR, Huang X, Boudeau J, Pawlowski R, Wullschleger S, Deak M, Ibrahim AF, Gourlay R, Magnuson MA, Alessi DR (2007) Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem J 405(3):513-522 (Pubitemid 47172049)
83. Pearce LR, Komander D, Alessi DR (2010) The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol 11(1):9-22
84. Pearn L, Fisher J, Burnett AK, Darley RL (2007) The role of PKC and PDK1 in monocyte lineage specification by Ras. Blood 109(10):4461-4469 (Pubitemid 46743416)
85. Peifer C, Alessi DR (2008) Small-molecule inhibitors of PDK1. ChemMedChem 3(12):1810-1838
86. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A 96(4):1563-1568 (Pubitemid 29098491)
87. Price DJ, Grove JR, Calvo V, Avruch J, Bierer BE (1992) Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257(5072):973-977
88. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G (1998) Phosphorylation and activation of p70s6k by PDK1. Science 279(5351):707-710
89. Rexhepaj R, Grahammer F, Volkl H, Remy C, Wagner CA, Sandulache D, Artunc F, Henke G, Nammi S, Capasso G, Alessi DR, Lang F (2006) Reduced intestinal and renal amino acid transport in PDK1 hypomorphic mice. FASEB J 20(13):2214-2222 (Pubitemid 44953851)
90. Richards SA, Fu J, Romanelli A, Shimamura A, Blenis J (1999) Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK. Curr Biol 9 (15):810-820 (Pubitemid 29375183)
91. Riojas RA, Kikani CK, Wang C, Mao X, Zhou L, Langlais PR, Hu D, Roberts JL, Dong LQ, Liu F (2006) Fine tuning PDK1 activity by phosphorylation at Ser163. J Biol Chem 281(31): 21588-21593 (Pubitemid 44181862)
92. Rotte A, Bhandaru M, Ackermann TF, Boini KM, Lang F (2008) Role of PDK1 in regulation of gastric acid secretion. Cell Physiol Biochem 22(5-6):725-734
93. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78(1):35-43 (Pubitemid 24228298)
94. Sandu C, Artunc F, Palmada M, Rexhepaj R, Grahammer F, Hussain A, Yun C, Alessi DR, Lang F (2006) Impaired intestinal NHE3 activity in the PDK1 hypomorphic mouse. Am J Physiol Gastrointest Liver Physiol 291(5):G868-G876 (Pubitemid 44772013)
95. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14(14):1296-1302 (Pubitemid 38991819)
96. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307(5712):1098-1101 (Pubitemid 40262113)
97. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, Coadwell J, Hawkins PT (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate- dependent activation of protein kinase B. Science 279(5351):710-714 (Pubitemid 28144551)
98. Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF, Holmes AB, McCormick F, Hawkins PT (1997) Dual role of phosphatidylinositol-3,4, 5-trisphosphate in the activation of protein kinase B. Science 277(5325):567-570 (Pubitemid 27369005)
99. Stroba A, Schaeffer F, Hindie V, Lopez-Garcia L, Adrian I, Frohner W, Hartmann RW, Biondi RM, Engel M (2009) 3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds. J Med Chem 52(15):4683-4693
100. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del BB I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTENtumor suppressor gene in mice. Curr Biol 8(21):1169-1178 (Pubitemid 28494715)
101. Thomas CC, Deak M, Alessi DR, Van Aalten DM (2002) High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to phosphatidylinositol (3,4,5)-trisphosphate. Curr Biol 12(14):1256-1262 (Pubitemid 34801176)
102. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G (2004) Absence of S6K1 protects against age-and dietinduced obesity while enhancing insulin sensitivity. Nature 431(7005):200-205 (Pubitemid 39243474)
103. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602 (Pubitemid 32662219)
104. Vasudevan KM, Barbie DA, Davies MA, Rabinovsky R, McNear CJ, Kim JJ, Hennessy BT, Tseng H, Pochanard P, Kim SY, Dunn IF, Schinzel AC, Sandy P, Hoersch S, Sheng Q, Gupta PB, Boehm JS, Reiling JH, Silver S, Lu Y, Stemke-Hale K, Dutta B, Joy C, Sahin AA, Gonzalez-Angulo AM, Lluch A, Rameh LE, Jacks T, Root DE, Lander ES, Mills GB, Hahn WC, Sellers WR, Garraway LA (2009) AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 16(1):21-32
105. Waugh C, Sinclair L, FinlayD,Bayascas JR, CantrellD(2009) Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation. Mol Cell Biol 29(21):5952-5962
106. Whiteman EL, Cho H, Birnbaum MJ (2002) Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 13(10):444-451 (Pubitemid 36733939)
107. Wick MJ, Ramos FJ, Chen H, Quon MJ, Dong LQ, Liu F (2003) Mouse 3-phosphoinositidedependent protein kinase-1 undergoes dimerization and trans-phosphorylation in the activation loop. J Biol Chem 278(44):42913-42919 (Pubitemid 37345902)
108. Williams MR, Arthur JS, Balendran A, van der KJ, Poli V, Cohen P, Alessi DR (2000) The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol 10(8):439-448 (Pubitemid 30247331)
109. Xie Z, Zeng X, Waldman T, Glazer RI (2003) Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 activates beta-catenin and c-Myc, and downregulates caveolin-1. Cancer Res 63(17):5370-5375 (Pubitemid 37139853)
110. Xie Z, Yuan H, Yin Y, Zeng X, Bai R, Glazer RI (2006) 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases. BMC Cancer 6:77
111. Yang J, Cron P, Good VM, Thompson V, Hemmings BA, Barford D (2002a) Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat Struct Biol 9(12):940-944 (Pubitemid 35417064)
112. Yang J, Cron P, Thompson V, Good VM, Hess D, Hemmings BA, Barford D (2002b) Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol Cell 9(6):1227-1240 (Pubitemid 34722302)
113. Yang Q, Inoki K, Ikenoue T, Guan KL (2006) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev 20(20):2820-2832 (Pubitemid 44771744)
114. Yang KJ, Shin S, Piao L, Shin E, Li Y, Park KA, Byun HS, Won M, Hong J, Kweon GR, Hur GM, Seok JH, Chun T, Brazil DP, Hemmings BA, Park J (2008) Regulation of 3-phosphoinositidedependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding. J Biol Chem 283(3):1480-1491
115. Yuan TL, Cantley LC (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27(41):5497-5510
116. Zaru R, Mollahan P, Watts C (2008) 3-phosphoinositide-dependent kinase 1 deficiency perturbs Toll-like receptor signaling events and actin cytoskeleton dynamics in dendritic cells. J Biol Chem 283(2):929-939
117. Zeng X, Xu H, Glazer RI (2002) Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase Calpha. Cancer Res 62(12):3538-3543 (Pubitemid 34651405)